Carregant...
Gene Therapy For Beta-Thalassemia: Updated Perspectives
Allogeneic hematopoietic stem cell transplantation was until very recently, the only permanent curative option available for patients suffering from transfusion-dependent beta-thalassemia. Gene therapy, by autologous transplantation of genetically modified hematopoietic stem cells, currently represe...
Guardat en:
| Publicat a: | Appl Clin Genet |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6765258/ https://ncbi.nlm.nih.gov/pubmed/31576160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TACG.S178546 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|